Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia

Deletions or monosomy of chromosomes 5 and 7 are frequently observed in myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). In this study two genes, PURA and PURB, encoding functionally cooperative proteins in the Pur family, are localized to chromosome bands 5q31.1 and 7p13, respectively. One or both of these loci are shown to be hemizygously deleted in 60 MDS or AML patients using fluorescence in situ hybridization (FISH). High-resolution mapping of PURA localizes it approximately 1.1 Mb telomeric to the EGR-1 gene. Frequency of PURA deletion and segregation with EGR-1 indicate that PURA is within the most commonly deleted segment in myeloid disorders characterized by del(5)(q31). No mutations have been detected within the coding sequence of PURA. Concurrent deletions of PURA and PURB occur in mds at a rate nearly 1.5-fold higher than statistically expected and in aml at a rate >5-fold higher. This novel simultaneous deletion of two closely related gene family members may thus have consequences related to progression to AML. Purα, an Rb-binding protein, has been implicated in cell cycle control and differentiation, and Purα and Purβ are reported to function as heterodimers. Alterations in these genes could affect a delicate balance critical in myeloid development.

[1]  K. Khalili,et al.  Molecular characterization and chromosomal localization of mouse Purα gene , 2000 .

[2]  C. Mecucci,et al.  Diagnosis, classification, and cytogenetics of myelodysplastic syndromes. , 1998, Haematologica.

[3]  P. Nowell,et al.  Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Cogan,et al.  Molecular Interactions between Single-stranded DNA-binding Proteins Associated with an Essential MCAT Element in the Mouse Smooth Muscle α-Actin Promoter* , 1999, The Journal of Biological Chemistry.

[5]  R. Gordon,et al.  Alterations in Pur(alpha) levels and intracellular localization in the CV-1 cell cycle. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[6]  D. Stacey,et al.  Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Puraα , 1999, Oncogene.

[7]  R. Espinosa,et al.  Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Bergemann,et al.  The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication , 1992, Molecular and cellular biology.

[9]  R. Larson,et al.  Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. , 1996, Blood.

[10]  B. Pedersen Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML. , 1996, Leukemia.

[11]  R. J. Kelm,et al.  Sequence of cDNAs Encoding Components of Vascular Actin Single-stranded DNA-binding Factor 2 Establish Identity to Purα and Purβ* , 1997, The Journal of Biological Chemistry.

[12]  J. Warrington,et al.  Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome. , 1994, Blood.

[13]  Phang-lang Chen,et al.  Association of Human Purα with the Retinoblastoma Protein, Rb, Regulates Binding to the Single-stranded DNA Purα Recognition Element (*) , 1995, The Journal of Biological Chemistry.

[14]  T. Waldmann,et al.  Human gamma-chain genes are rearranged in leukaemic T cells and map to the short arm of chromosome 7. , 1985, Nature.

[15]  B. Johansson,et al.  Primary vs. secondary neoplasia‐associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances? , 1996, Genes, chromosomes & cancer.

[16]  R. Wing,et al.  Construction and characterization of a bovine bacterial artificial chromosome library. , 1995, Genomics.

[17]  Edward M. Johnson,et al.  Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein , 1992, Molecular and cellular biology.

[18]  L. Chepenik,et al.  Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  al. et,et al.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.

[20]  D. Stacey,et al.  Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alpha. , 1999, Oncogene.

[21]  M. Permutt,et al.  A 2-cM genetic linkage map of human chromosome 7p that includes 47 loci. , 1992, Genomics.

[22]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[23]  L. Michaux,et al.  5q-, twenty-five years later: a synopsis. , 1997, Cancer genetics and cytogenetics.

[24]  B. Birren,et al.  Construction and characterization of a human bacterial artificial chromosome library. , 1996, Genomics.

[25]  N. Zhao,et al.  Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Boultwood,et al.  Chromosomal deletions in myelodysplasia. , 1995, Leukemia & lymphoma.

[27]  S. Schuffenhauer,et al.  Cyclophilin A, the major intracellular receptor for the immunosuppressant cyclosporin A, maps to chromosome 7p11.2-p13: four pseudogenes map to chromosomes 3, 10, 14, and 18. , 1995, Genomics.

[28]  M. L. Le Beau,et al.  The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. , 1988, Science.

[29]  P. Nilsson,et al.  Correlation of Karyotype and Occupational Exposure to Potential Mutagenic/Carcinogenic Agents in Acute Nonlymphocytic Leukemia , 1984 .

[30]  P. D. de Jong,et al.  BAC and PAC contigs covering 3.5 Mb of the Down syndrome congenital heart disease region between D21S55 and MX1 on chromosome 21. , 1997, Genomics.

[31]  R. Larson,et al.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  G. Yusibova,et al.  Identification of a cellular protein that binds to tat‐responsive element of TGFβ‐1 promoter in glial cells , 1997 .

[33]  B. Iacopetta,et al.  A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[34]  L. Nagarajan,et al.  Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms. , 2000, Blood.

[35]  K Georgopoulos,et al.  The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. , 1996, Journal of immunology.

[36]  C. Bloomfield,et al.  Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[37]  C. Mecucci,et al.  Characterization of deletions of chromosome 7 short arm occurring as primary karyotypic anomaly in acute myeloid leukaemia , 1989, British journal of haematology.

[38]  C. Bloomfield,et al.  Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. , 1994, Cancer genetics and cytogenetics.

[39]  A. Bergemann,et al.  Conservation in human and mouse Pur alpha of a motif common to several proteins involved in initiation of DNA replication. , 1994, Gene.

[40]  D. Hoelzer,et al.  High resolution physical mapping of human HDAC3, a potential tumor suppressor gene in the 5q31 region , 1999, Cytogenetic and Genome Research.

[41]  K. Khalili,et al.  A 39-kD DNA-binding protein from mouse brain stimulates transcription of myelin basic protein gene in oligodendrocytic cells , 1995, The Journal of cell biology.

[42]  G. Gallia,et al.  Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha , 1996, Journal of virology.

[43]  D. Ward,et al.  Two diverged human homeobox genes involved in the differentiation of human hematopoietic progenitors map to chromosome I, bands q41–42.I , 1992 .

[44]  P. Nilsson,et al.  Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation of karyotype and occupational exposure to potential mutagenic/carcinogenic agents in acute nonlymphocytic leukemia. , 1984, Cancer genetics and cytogenetics.

[45]  R. Fulton,et al.  A physical map of human chromosome 7: an integrated YAC contig map with average STS spacing of 79 kb. , 1997, Genome research.

[46]  B. Johansson,et al.  Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor Loci , 1993, Genes, chromosomes & cancer.

[47]  D. Ward,et al.  Localization of PURA, the gene encoding the sequence-specific single-stranded-DNA-binding protein Pur alpha, to chromosome band 5q31. , 1995, Cytogenetics and cell genetics.

[48]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[49]  P. Nowell,et al.  Physical mapping of the minimal region of loss in 5q- chromosome. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[51]  F. Mitelman ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[52]  C. Bloomfield,et al.  Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[53]  B. Birren,et al.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Z. Arbieva,et al.  Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. , 2000, Blood.

[55]  J. Zavadil,et al.  Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60 , 1997, Leukemia.